Synthesis and evaluation of butein derivatives for in vitro and in vivo inflammatory response suppression in lymphedema
Lipopolysaccharides
0303 health sciences
Tumor Necrosis Factor-alpha
Anti-Inflammatory Agents
Rats
3. Good health
Mice
03 medical and health sciences
Chalcones
Macrophages, Peritoneal
Microsomes, Liver
Animals
Humans
Prodrugs
Lymphedema
DOI:
10.1016/j.ejmech.2020.112280
Publication Date:
2020-04-06T15:10:26Z
AUTHORS (7)
ABSTRACT
Herein, we demonstrate that butein (1) can prevent swelling in a murine lymphedema model by suppressing tumor necrosis factor α (TNF-α) production. Butein derivatives were synthesized and evaluated to identify compounds with in vitro anti-inflammatory activity. Among them, 20 μM of compounds 7j, 7m, and 14a showed 50% suppression of TNF-α production in mouse peritoneal macrophages after lipopolysaccharide stimulation. Compound 14a, exhibited the strongest potency with an in vitro IC50 of 14.6 μM and suppressed limb volume by 70% in a murine lymphedema model. The prodrug strategy enabled a six-fold increase in kinetic solubility of compound 1 and five-fold higher levels of active metabolite in the blood for compound 14a via oral administration in the pharmacokinetics study. We suggest that the compound 14a could be developed as a potential therapeutic agent targeting anti-inflammatory activity to alleviate lymphedema progression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....